|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.300 SEK | +0.39% |
|
-3.35% | -37.20% |
| 17/06 | Axichem AB Elects Michael Engstrom As Chairman Of The Board | RE |
| 12/06 | Calendar Monday June 15 - Friday June 19 | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 43.62L | 50.07L | 18.09L | 85.7L | 1.84Cr | |||||
Total Revenues | 43.62L | 50.07L | 18.09L | 85.7L | 1.84Cr | |||||
Cost of Goods Sold, Total | 34.53L | 11.89L | 4L | 14.89L | 93.65L | |||||
Gross Profit | 9L | 38.18L | 14.09L | 70.81L | 90.81L | |||||
Selling General & Admin Expenses, Total | 1.3Cr | 1.48Cr | 1.55Cr | 1.81Cr | 2.11Cr | |||||
Depreciation & Amortization - (IS) | 24.74L | 35.11L | 38.34L | 42.77L | 48.96L | |||||
Other Operating Expenses | 5L | 91T | -6L | 5L | 6L | |||||
Other Operating Expenses, Total | 1.6Cr | 1.84Cr | 1.87Cr | 2.29Cr | 2.66Cr | |||||
Operating Income | -1.51Cr | -1.45Cr | -1.73Cr | -1.58Cr | -1.75Cr | |||||
Interest Expense, Total | -2T | -26.9L | -34.71L | -19.56L | -1L | |||||
Interest And Investment Income | 14T | - | - | - | - | |||||
Net Interest Expenses | 12T | -26.9L | -34.71L | -19.56L | -1L | |||||
Income (Loss) On Equity Invest. | - | - | - | - | - | |||||
Currency Exchange Gains (Loss) | - | - | - | - | - | |||||
EBT, Excl. Unusual Items | -1.51Cr | -1.72Cr | -2.08Cr | -1.78Cr | -1.76Cr | |||||
EBT, Incl. Unusual Items | -1.51Cr | -1.72Cr | -2.08Cr | -1.78Cr | -1.76Cr | |||||
Income Tax Expense | 35T | 25T | 25T | 32T | 27T | |||||
Earnings From Continuing Operations | -1.51Cr | -1.73Cr | -2.08Cr | -1.78Cr | -1.76Cr | |||||
Net Income to Company | -1.51Cr | -1.73Cr | -2.08Cr | -1.78Cr | -1.76Cr | |||||
Minority Interest | - | 3T | 3T | 2T | 3T | |||||
Net Income - (IS) | -1.51Cr | -1.73Cr | -2.08Cr | -1.78Cr | -1.76Cr | |||||
Net Income to Common Incl Extra Items | -1.51Cr | -1.73Cr | -2.08Cr | -1.78Cr | -1.76Cr | |||||
Net Income to Common Excl. Extra Items | -1.51Cr | -1.73Cr | -2.08Cr | -1.78Cr | -1.76Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.92 | -1.04 | -1.03 | -0.46 | -0.3 | |||||
Basic EPS - Continuing Operations | -0.92 | -1.04 | -1.03 | -0.46 | -0.3 | |||||
Basic Weighted Average Shares Outstanding | 1.63Cr | 1.65Cr | 2.03Cr | 3.85Cr | 5.91Cr | |||||
Net EPS - Diluted | -0.92 | -1.04 | -1.03 | -0.46 | -0.3 | |||||
Diluted EPS - Continuing Operations | -0.92 | -1.04 | -1.03 | -0.46 | -0.3 | |||||
Diluted Weighted Average Shares Outstanding | 1.63Cr | 1.65Cr | 2.03Cr | 3.85Cr | 5.91Cr | |||||
Normalized Basic EPS | -0.58 | -0.65 | -0.64 | -0.29 | -0.19 | |||||
Normalized Diluted EPS | -0.58 | -0.65 | -0.64 | -0.29 | -0.19 | |||||
Supplemental Items | ||||||||||
EBITDA | -1.35Cr | -1.24Cr | -1.51Cr | -1.35Cr | -1.5Cr | |||||
EBITA | -1.35Cr | -1.25Cr | -1.51Cr | -1.35Cr | -1.5Cr | |||||
EBIT | -1.51Cr | -1.45Cr | -1.73Cr | -1.58Cr | -1.75Cr | |||||
EBITDAR | - | - | - | - | - | |||||
Total Revenues (As Reported) | 44.37L | 52.18L | 26.76L | 89.6L | 1.9Cr | |||||
Effective Tax Rate - (Ratio) | -0.23 | -0.14 | -0.12 | -0.18 | -0.15 | |||||
Total Current Taxes | 35T | 25T | 25T | 32T | 27T | |||||
Normalized Net Income | -94.11L | -1.08Cr | -1.3Cr | -1.11Cr | -1.1Cr | |||||
Interest on Long-Term Debt | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 9L | 14.03L | 16.19L | 19.29L | 24.2L | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - |
- Stock Market
- Stocks
- AXIC A Stock
- Financials aXichem AB
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















